New antibody-chemo combo shows promise against tough breast cancer
NCT ID NCT05181462
First seen Apr 07, 2026 · Last updated May 16, 2026 · Updated 6 times
Summary
This study tests a new drug called nadunolimab, given together with standard chemotherapy, for people with advanced triple-negative breast cancer. The goal is to see if the combination is safe and can shrink tumors better than chemo alone. About 117 adults with this aggressive cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clínica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Complejo Hospitalario Universitario A Coruña
A Coruña, Galicia, 15006, Spain
-
Complejo Hospitalario Universitario de Albacete
Albacete, Castille-La Mancha, 02006, Spain
-
Complejo Hospitalario de Jaén
Jaén, Andalusia, 23007, Spain
-
Fundación Instituto Valenciano de Oncología
Valencia, Valencia, 46009, Spain
-
Hospital Clinic de Barcelona
Barcelona, Catalonia, 08036, Spain
-
Hospital Clínico San Carlos
Madrid, Madrid, 28040, Spain
-
Hospital Clínico Universitario Lozano Blesa
Zaragoza, Aragon, 50009, Spain
-
Hospital Materno Infantil de Gran Canaria
Las Palmas de Gran Canaria, Las Palmas, 35016, Spain
-
Hospital Universitario 12 de Octubre
Madrid, Madrid, 28041, Spain
-
Hospital Universitario Arnau de Vilanova Lleida
Lleida, Catalonia, 25198, Spain
-
Hospital Universitario Clinico San Cecilio
Granada, Andalusia, 18016, Spain
-
Hospital Universitario Gregorio Marañón
Madrid, Madrid, 28007, Spain
-
Hospital Universitario Lucus Augusti
Lugo, Galicia, 27003, Spain
-
Hospital Universitario San Juan de Alicante
Alicante, Valencia, 03550, Spain
-
Hospital Universitario Virgen De La Victoria
Málaga, Andalusia, 29010, Spain
-
Hospital Universitario Virgen Del Rocío
Seville, Andalusia, 41013, Spain
-
Hospital Universitario Virgen Macarena
Seville, Andalusia, 41009, Spain
-
Hospital Universitario Virgen de las Nieves
Granada, Andalusia, 18014, Spain
-
Hospital Universitario de Toledo
Toledo, Castille-La Mancha, 45007, Spain
-
Hospital del Mar
Barcelona, Catalonia, 08003, Spain
-
ICO Institut Catalá d'Oncologia de L´Hospitalet
Hospitalet de Llobregat, Barcelona, Catalonia, 08908, Spain
-
Onkologikoa
Donostia / San Sebastian, Basque Country, 20014, Spain
Conditions
Explore the condition pages connected to this study.